ESPE Abstracts (2022) 95 P1-58

ESPE2022 Poster Category 1 Diabetes and Insulin (86 abstracts)

Developing a digital Southeast Asia Type 1 diabetes healthcare educational platform in local languages during the pandemic

Sze May Ng 1,2 , Malene IV 3 , Thy Khue Nguyen 4 , Khuong Le 5 , Yang Xian Lucas Lim 6 , Ngee Lek 7 , Azriyanti Anuar Zaini 8 , Samantha Seal 9 , Steffen Yun Tange 10 , Anne Charlotte Ficheroulle 11 & Charles Toomey 11

48 views


1Southport and Ormskirk Hospital NHS, Southport, United Kingdom; 2University of Liverpool, Liverpool, United Kingdom; 3Kantha Bopha Children's Hospital, Phnom Penh, Cambodia; 4Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh, Vietnam; 5National Yang Ming Chiao Tung University, Taipei, Taiwan; 6Dietitian 90 Consultancy, Georgetown, Malaysia; 7KK Women’s and Children’s Hospital, Singapore, Singapore; 8University of Malaya, Kuala Lumpur, Malaysia; 9T1D advocate, Bangkok, Thailand; 10Summit Consulting, Copenhagen, Denmark; 11Action4Diabetes, Somerset, United Kingdom


Introduction: Action4Diabetes (A4D) is a non-profit UK organisation formed in 2016 that is making sustainable and scalable progress to provide quality Type 1 diabetes (T1D) healthcare in Southeast Asia (SEA). A4D provides comprehensive partnership programmes through a Memorandum of Understanding (MOU) signed with the governments in SEA that guarantees ongoing supplies of free insulin, blood glucose testing, HbA1c tests and hospital emergency funds in low-middle-income countries (LMICs)-Laos, Malaysia, Vietnam, Cambodia, Thailand and Myanmar. During the pandemic, in 2020-2021 in collaboration with SEA local healthcare professionals, A4D developed HelloType1 an innovative digital healthcare educational resource platform of T1D in SEA local languages for healthcare professionals, families and people with T1D.

Objective: To educate, engage and empower healthcare professionals, families and people with T1D by creating a digital platform that is free-to-access and provides accurate up-to-date information, patient-oriented education and best practice care about T1D care in SEA local languages.

Methods: HelloType1 content has been designed for 2 core audiences. A user option of choosing either ‘healthcare professional’ or ‘people living with T1D and caregivers’ on entry to the website. It covers 8 core topics and content is curated using information from accredited sources such as International Diabetes Foundation (IDF) and International Society for Paediatric and Adolescent Diabetes (ISPAD). All content was reviewed and translated to local languages by a panel T1D healthcare experts and lay people with T1D to ensure that the information was appropriate in the local context. HelloType1 was launched in English, Khmer and Vietnamese languages in 2021-March 2022. Adaptation in Thai, Bahasa, Burmese and Laotian languages will be launched in August-October 2022. A Facebook page was created for each country in their local languages for signposting to the HelloType1 websites.

Results: There was an 80% increase in the number of users and 113% increase in the number of pages visited (Pageviews) between Q3 and Q4 2021 in English and Khmer languages. 53% of pageviews were coming from healthcare professionals and 47% from families and people with T1D. The HelloType1 Cambodia Facebook analytics showed approximately 1000 followers and had a 4% increase each month. On average, 3 posts were published weekly which generated a monthly average reach of 4000.

Conclusion: Strengthening health systems and developing sustainable and locally owned solutions are vital to improve health and quality of life of people with T1D. This requires universal coverage, upskilling and education to close the T1D gaps in SEA.

Volume 95

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.